19 results
424B3
RGBP
Regen BioPharma, Inc.
20 Nov 23
Prospectus supplement
9:38am
financial position, business strategy, budgets, projected costs and plans and objectives of management for future operations, are forward-looking … of operations, business strategy and financial needs. The forward-looking statements can be affected by inaccurate assumptions or by known or unknown
8-K
RGBP
Regen BioPharma, Inc.
19 Oct 21
Entry into a Material Definitive Agreement
9:30am
with regulatory strategy with regard to the Company’s NR2F6 intellectual property . Total consideration to be paid by the Company to Biotech Research Group
8-K
EX-10.1
sioof
19 Oct 21
Entry into a Material Definitive Agreement
9:30am
10-K
io5b 6chkz1o204pu7g
18 Dec 14
Annual report
12:00am
424B3
ii87aso1kwaqnkbu80
19 Mar 14
Prospectus supplement
12:00am
S-1/A
cq1unppwj0kbk87j3cu
22 Nov 13
IPO registration (amended)
12:00am
- Prev
- 1
- Next